HeartFlow’s AI-enabled plaque quantification technology has been upgraded to a new I CPT category code by the American Medical Association.

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

Relaxed glycemic control targets were associated with an increased risk for skin, bone, and soft tissue infections among older adults with type 2 diabetes. Older adults with type 2 diabetes and ...

Individuals with primary biliary cholangitis and diabetes may experience worse outcomes, such as progression to end-stage liver disease.

Continuous moderate-level maternal psychological distress throughout pregnancy is associated with a heightened risk for epilepsy among offspring.

Authors say technology may enable noninvasive screening. HealthDay News — Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and ...

Individuals with lower health literacy may have more advanced metabolic dysfunction-associated steatotic liver disease. Lower health literacy is associated with greater disease severity in metabolic ...

No significant effects were seen for neighborhood noise alone or in combination with sleep health. HealthDay News — In adolescents, adequate sleep is associated with a reduced risk for hypertension, ...

Detailed results were announced from the phase 3 SUMMIT trial evaluating the use of tirzepatide in adults with HFpEF and obesity.

Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreservation (OC) have complications.

The increased risks for arterial thrombotic events (ATE), venous thromboembolism (VTE), and all-cause mortality known to be found among patients with systemic lupus erythematosus (SLE) were validated ...

Adults with type 2 diabetes (T2D) have an increased risk for mortality in association with low income, with the most prominent increase seen for adults aged 20 to 39 years.